Literature DB >> 12116291

Assessment of spinal cord pathology following trauma using early changes in the spinal cord evoked potentials: a pharmacological and morphological study in the rat.

Hari Shanker Sharma1, Tomas Winkler.   

Abstract

The possibility that spinal cord pathology following trauma can be assessed with early changes in the spinal cord evoked potentials (SCEPs) was examined in a rat model. Spinal cord injury (SCI) was produced in Equithesin-anesthetized (3 ml/kg, i.p.) rats through a longitudinal incision into the right dorsal horn at the T10-11 segments. The SCEPs were recorded with epidural electrodes placed over the T9 (rostral) segment of the cord. The SCEPs consisted of a small positive amplitude and a broad and high negative amplitude (NA). SCI resulted in an instant depression of the rostral NA that lasted for 1 h. However, the latency of NA continued to increase over time. At 5 h, spinal cord blood flow declined by 30% in the T9 segment, whereas the spinal cord water content and the permeability of the blood-spinal cord barrier (BSCB) were markedly increased. Damage to the nerve cells, glial cells, and myelin was quite common in the spinal cord, as seen by light and electron microscopy. Pretreatment with p-chlorophenylalanine, indomethacin, ibuprofen, and nimodipine attenuated the SCEP changes immediately after trauma and resulted in a marked reduction in edema formation, BSCB permeability, and blood flow changes at 5 h. However, pretreatment with cyproheptadine, dexamethasone, phentolamine, and propranolol failed to attenuate the SCEP changes after SCI and did not reduce the cord pathology. These observations suggest that early changes in SCEP reflect secondary injury-induced alterations in the cord microenvironment. Obviously, these changes are crucial in determining the ultimate magnitude and severity of cord pathology. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116291     DOI: 10.1002/mus.10152

Source DB:  PubMed          Journal:  Muscle Nerve Suppl


  7 in total

Review 1.  A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.

Authors:  Brian K Kwon; Elena Okon; Jessica Hillyer; Cody Mann; Darryl Baptiste; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-04-14       Impact factor: 5.269

Review 2.  Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection.

Authors:  Hari Shanker Sharma
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

Review 3.  Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.

Authors:  Jeffrey J Lochhead; Patrick T Ronaldson; Thomas P Davis
Journal:  AAPS J       Date:  2017-03-28       Impact factor: 4.009

Review 4.  Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury.

Authors:  M A Kopp; T Liebscher; A Niedeggen; S Laufer; B Brommer; G J Jungehulsing; S M Strittmatter; U Dirnagl; J M Schwab
Journal:  Cell Tissue Res       Date:  2012-02-21       Impact factor: 5.249

5.  Quantitative iTRAQ proteomics reveal the proteome profiles of bone marrow mesenchymal stem cells after cocultures with Schwann cells in vitro.

Authors:  Han Ding; Ang Li; Chao Sun; Jianping Zhang; Jun Shang; Haoshuai Tang; Junjin Li; Min Wang; Xiaohong Kong; Zhijian Wei; Shiqing Feng
Journal:  Ann Transl Med       Date:  2022-09

Review 6.  The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders.

Authors:  Marcos F DosSantos; Rosenilde C Holanda-Afonso; Rodrigo L Lima; Alexandre F DaSilva; Vivaldo Moura-Neto
Journal:  Front Cell Neurosci       Date:  2014-10-08       Impact factor: 5.505

Review 7.  Neurovascular unit in chronic pain.

Authors:  Beatrice Mihaela Radu; Placido Bramanti; Francesco Osculati; Maria-Luisa Flonta; Mihai Radu; Giuseppe Bertini; Paolo Francesco Fabene
Journal:  Mediators Inflamm       Date:  2013-06-05       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.